To help you compare the National Institutes of Health’s (NIH’s) recommended COVID-19 outpatient therapies, the Texas Medical Association has created a chart with information on each of the four recommended drugs in the NIH’s listed preference order: nirmatrelvir plus ritonavir, sotrovimab, remdesivir, and molnupiravir.
The chart includes dosages, situational considerations (such as whether the patient can continue on the drug if hospitalized during the therapy), contraindications, and more. Also included are links to fact sheets and locators for the treatments.
You can download the chart, and find much more information, on TMA’s COVID-19 Resource Center.
Last Updated On
April 05, 2022
Originally Published On
January 26, 2022